Advertisement
Organisation › Details
Qiagen N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA)
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). As of September 30, 2014, QIAGEN employed approximately 4,200 people in over 35 locations worldwide. *
Start | 1997-01-01 existent | |
Group | Qiagen (Group) | |
Predecessor | Diagen | |
Industry | sample preparation (technology) | |
Industry 2 | molecular diagnostics | |
Person | Bernard, Thierry (Qiagen 201502– SVP Molecular Dx business area before bioMérieux Corp VP Commcercial Operations) | |
Person 2 | Sackers, Roland (Qiagen 200408 CFO) | |
Street | 50 Spoorstraat | |
City | 5911 KJ Venlo | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | G: 5,001 to 10,000 (2022-12-31) |
Currency | USD | |
Annual sales | 2,141,518,000 (net sales, consolidated (2022) 2022-12-31) | |
Profit | 423,211,000 (2022-12-31) | |
Cash | 730,669,000 (2022-12-31) | |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Qiagen (Group)
- [1] Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA....
- [2] Evonetix Ltd.. (6/13/22). "Press Release: Colin McCracken Joins Evonetix as Chief Executive Officer"....
- [3] Qiagen N.V.. (5/17/21). "Press Release: Qiagen Announces Creation of Scientific Advisory Board and Agenda for Annual General Meeting in June 2021". Venlo....
- [4] Qiagen N.V.. (1/7/21). "Press Release: Qiagen Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute". Redwood City, CA & Hilden....
- [5] Qiagen N.V.. (2/4/19). "Press Release: Qiagen Informatics Solutions Chosen to Support Genomics England’s Bold Five Million Genomes in Five Years Project". Hilden & London....
- [6] Qiagen N.V.. (7/11/18). "Press Release: Qiagen Partners with U.K. to Expand Biomarker Research in Manchester". Manchester & Hilden....
- [7] Qiagen N.V.. (10/24/17). "Press Release: Qiagen and ICMP Launch Next-generation DNA Testing Solutions for Identifying Missing Persons". The Hague....
- [8] Oxford Immunotec Global plc. (9/27/17). "Press Release: Oxford Immunotec Announces Update in Patent Infringement Litigation". Oxford & Marlborough, MA....
- [9] Qiagen N.V.. (1/30/17). "Press Release: Qiagen Hereditary and Rare Disease Solution Chosen by Genomics England". Hilden & London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top